Protocols
24 protocol(s) meet the specified criteria
Disease Site: Prostate
Protocol No.TitleStatus
16-2485Prospective Validation of Prostate Biomarkers for Repeat Biopsy: The PRIORITY StudyOpen
17-2163True NTH Sexual Recovery Intervention for Prostate Cancer SurvivorsOpen
AFT-19A Phase 3 Study of Androgen Annihilation in High-Risk Biochemically Relapsed Prostate CancerOpen
AMC-095A Phase I Study of Ipilimumab and Nivolumab in Advanced HIV Associated Solid Tumors with an Expansion Cohort in HIV Associated Solid Tumors and a Cohort of HIV-Associated Classical Hodgkin LymphomaOpen
APEC1621SCNCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)Open
C16-168A Randomized Phase II Trial of Abiraterone, Olaparib, or Abiraterone + Olaparib in Patients with Metastatic Castration-Resistant Prostate Cancer with DNA Repair DefectsOpen
C16-170Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men with Advanced Prostate Cancer (IRONMAN)Open
GO30140An Open-Label, Multicenter Phase Ib Study of the Safety and Tolerability of Atezolizumab (ANTI-PD L1 Antibody) Administered in combination with Bevacizumab and/or other Treatments in Patients with Solid Tumors.Open
INCAGN1876-201A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of INCAGN01876 in Combination with Immune therapies in Subjects with Advanced or Metastatic MalignanciesOpen
LCCC1512Evaluation of the accuracy of new-generation pedometers in older adult patients with advanced cancers Open
LCCC1613Feasibility Study of a Home-based Exercise Intervention Program for Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Androgen-Deprivation Therapy (ADT)Open
LCCC1619Enhancing Survivorship Care Planning for Patients with Localized Prostate Cancer Using A Couple-focused Web-based Tailored Symptom Self-management ProgramOpen
LCCC1623Interviewing cancer patients and caregivers about using symptom questionnaires to improve quality of cancer careOpen
LCCC1635Pilot study evaluating the microbiome in bladder and prostate cancer patientsOpen
LCCC1636Using PROMIS as part of routine clinical care for racially diverse prostate and bladder cancer patientsOpen
LCCC1713Testing the Efficacy of a Couple-Focused, Tailored Ehealth Intervention for Symptom Self-Management Among Men with Prostate Cancer and Their PartnersOpen
LCCC1734Adaptation of the Parenting Concerns Questionnaire for Patients with IllnessOpen
MCC-16962A Phase I Trial of Dose Escalation of Metformin in Combination with Vincristine, Irinotecan, and Temozolomide in Children with Relapsed or Refractory Solid TumorsOpen
MDT16075OsteoCool Tumor Ablation Post-Market Study (OPuS One)Open
ML28897PRO/02My Pathway: An Open-Label Phase IIA Study Evaluating Trastuzumab/Pertuzumab, Erlotinib, Vemurafenib/Cobimetinib, and Vismodegib in Patients who have Advanced Solid Tumors with Mutations or Gene Expression Abnormalities Predictive of Response to one of these Agents.Open
NC-6300-001A Phase 1b/2 Dose-Escalation and Expansion Trial of NC-6300 (Nanoparticle Epirubicin) in Patients with Advanced Solid Tumors or Advanced, Metastatic, or Unresectable Soft Tissue SarcomaOpen
NRG-GU003A Randomized Phase III Trial of Hypofractionated Post-Prostatectomy Radiation Therapy (Hyport) Versus Conventional Post-Prostatectomy Radiation Therapy (Coport)Open
ONC-MA-1004A Prospective Observational Cohort Study of Patients with Castration-Resistant Prostate Cancer (CRPC) in the United StatesOpen
RTOG0815A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy with or without Short-term Androgen Deprivation Therapy for Patients with Intermediate-Risk Prostate Cancer Open (affiliates only)